Paula Lindner
banner
drpaulalindner.bsky.social
Paula Lindner
@drpaulalindner.bsky.social
Scientific Product Manager at Gentian
#DiagnosticEfficiency #Biomarkers

#Calprotectin #Rheumatology #RheumSky
#NT-proBNP #CardioSky

Views expressed are my own.
Pinned
🗣️Webinar by Prof. Dr. Marija Jeluŝić now available on demand 🌐

Serum Calprotectin (S100A8/A9) in Diagnosis, Monitoring, and Prognosis of Rheumatic Diseases

selectscience.streamgo.live/serum-calpro...

#RheumaSky #Calprotectin #Inflammation
Serum Calprotectin (S100A8/A9) in Diagnosis, Monitoring, and Prognosis of Rheumatic Diseases
<p><strong>Available On-Demand</strong></p> <p>Serum calprotectin plays a critical role in the pathogenesis of rheumatoid arthritis (RA), as it triggers chemotaxis, phagocyte migration, and modulation...
selectscience.streamgo.live
Exploring the Relevance of S100A8 and S100A9 Proteins in Preeclampsia: A Narrative Review

#Calprotectin

www.mdpi.com/1422-0067/26...
November 4, 2025 at 2:20 PM
The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies

#CardioSky #calprotectin

www.nmcd-journal.com/article/S093...
The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies
Low-grade inflammation is a key driver of the pathogenesis and complications of acute coronary syndromes (ACS), playing a central role in plaque development and destabilization. This systematic review...
www.nmcd-journal.com
October 28, 2025 at 11:55 AM
𝗡𝗲𝘄 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗶𝗻𝘁𝗼 𝗲𝗮𝗿𝗹𝘆 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗼𝗳 𝗻𝗲𝗼𝗻𝗮𝘁𝗮𝗹 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 At this year’s joint European Neonatal Societies #jENS2025 Congress, new evidence will be presented on the role of serum #calprotectin in improving early diagnosis of neonatal infections.

www.gentian.com/news/calprot...
Calprotectin in neonatal infections - jENS Congress 2025
New evidence will be shared on the role of blood calprotectin in the early diagnosis of neonatal infections.
www.gentian.com
October 23, 2025 at 8:25 AM
Neutrophil activation in juvenile dermatomyositis: associations with muscle function and disease progression

#CirculatingCalprotectin and MPO-DNA as potential biomarkers for JDM muscle inflammation and functional outcomes.

#RheumSky

ped-rheum.biomedcentral.com/articles/10....
Neutrophil activation in juvenile dermatomyositis: associations with muscle function and disease progression - Pediatric Rheumatology
Background Juvenile dermatomyositis (JDM) is an inflammatory vasculopathy characterized by muscle weakness and systemic inflammation. This study aimed to investigate the clinical utility of neutrophil...
ped-rheum.biomedcentral.com
October 15, 2025 at 7:08 AM
👉Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive protein

#RheumSky #CirculatingCalprotectin

rmdopen.bmj.com/content/11/3...
Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive protein
Objectives C reactive protein (CRP) is frequently normal in psoriatic arthritis (PsA) despite active disease, complicating inflammation assessment. This study aimed to evaluate alternative biomarkers ...
rmdopen.bmj.com
October 6, 2025 at 7:32 AM
Great depate at #PReS2025 between Dirk Föll and Joost Swart. Engaging and entertaining to follow those 2 outstanding speakers exchanging arguments.

The futures will hopefully be personalised medicine also for IRDs and biomarkers will play a crucial role.

#RheumSky #calprotectin
September 18, 2025 at 8:51 AM
Year in review at #PReS2025 highlighting again the new Still's recommendations, endorsing biomarkers in diagnosis including #calprotectin

Visit us at booth 4 to learn about Gentian GCAL an automated calprotectin assay.

#RheumSky
September 17, 2025 at 5:14 PM
Highlight from Year in review at #PReS2025 S100A9 (#calprotectin subunit) at baseline predictive of long-term outcome after 18 years! #RheumSky
September 17, 2025 at 5:11 PM
#PRES2025 back in Helsinki after 30 years. Great start of the congress at the opening ceremony in this fascinating city.
September 17, 2025 at 3:15 PM
🧬 Review: S100A8/A9 (#calprotectin) drives inflammation in CVD - fueling atherosclerosis, HF & arrhythmias.
🔍 Promising biomarker & therapeutic target

👉The alarmin tandem: unraveling the complex effect of S100A8/A9 – from atherosclerosis to cardiac arrhythmias

www.frontiersin.org/journals/imm...
September 16, 2025 at 12:14 PM
👉 Visit Gentian at Booth 4 at #PReS2025 to discover how GCAL® #calprotectin improves early inflammation detection, flare prediction, and treatment monitoring in pediatric rheumatology.
September 15, 2025 at 12:50 PM
The countdown has started. Looking forward to yet another exciting year at #PReS2025 #RheumSky
September 11, 2025 at 7:28 AM
Day 2 at #ESC2025. Packed with engaging sessions.

Extra shout-out to the paper badge holders, nice alternative to the usual plastic versions. 💚
August 30, 2025 at 12:56 PM
Countdown to Friday!

Join me together with the cardiology community at #ESCCongress 2025 with #WCCCardio. See you there! bit.ly/2SuZgbc

#CardioSky
August 25, 2025 at 12:38 PM
💥 New biomarker insight for #pulmonaryembolism
#Calprotectin is up in PE and tracks with worse RV function (↓TAPSE, ↓RV-Sm). No link to D-dimer or troponin.

Potential new RV stress marker?

pmc.ncbi.nlm.nih.gov/articles/PMC...
August 5, 2025 at 12:17 PM
New biomarkers (of the 2024 recommendations) remain underutilized. S100 proteins ( #calprotectin ) are used by only 27% and 40% of respondents indicated lack of access.

But calprotectin is available as automated assay for labs (Siemens, Beckman and open channel).

pubmed.ncbi.nlm.nih.gov/40629829/
August 4, 2025 at 10:25 AM
👏 SelectScience editorial on #CirculatingCalprotectin received an award for the best ''Clinical Diagnostics Editorial Article of the Year'' at #ADLM this year.

#RheumSky

www.selectscience.net/article/how-...
How serum calprotectin is transforming rheumatic disease diagnosis
Discover how serum calprotectin is advancing the diagnosis, monitoring, and treatment of rheumatic diseases. Learn about its role in predicting flare-ups and guiding personalized care.
www.selectscience.net
August 4, 2025 at 8:19 AM
👉Where Do We Stand in the Management of Rheumatoid Arthritis Ahead of EULAR/ACR 2025?

#RheumSky #Rheumatology

www.mdpi.com/2039-7283/15...
July 4, 2025 at 12:04 PM
''Serum S100A8/A9 concentration at ICU admission is a significant predictor of 28-day mortality risk in sepsis patients''

#CirculatingCalprotectin #Sepsis

www.frontiersin.org/journals/cel...
Frontiers | Assessment of S100A8/A9 and resistin as predictive biomarkers for mortality in critically ill patients with sepsis
IntroductionSepsis is associated with high mortality. Early intervention is crucial to reducing sepsis-related mortality. This study aims to assess the clini...
www.frontiersin.org
July 1, 2025 at 12:40 PM
Review: Biomarkers in juvenile idiopathic arthritis: towards precision diagnosis and personalized therapy?

#CirculatingCalprotectin as promising tool for monitoring and prognosis in JIA by its ability to predict flares and subclinical inflammation.

#RheumSky

journals.lww.com/co-rheumatol...
Biomarkers in juvenile idiopathic arthritis: towards... : Current Opinion in Rheumatology
years, research has increasingly focused on the identification and validation of biomarkers to enhance diagnostic precision, predict disease course, and guide therapeutic decisions. Recent findings ...
journals.lww.com
June 24, 2025 at 12:15 PM
Reposted by Paula Lindner
#MedNews - Calprotectin could serve as a biomarker for #ASCVD beyond the current traditional cardiovascular risk factors.

Read the full story 👉 buff.ly/GxJoGHM

#CardioSky #calprotectin
Calprotectin shows potential as a biomarker for atherosclerotic CV disease risk
Calprotectin could serve as a biomarker for atherosclerotic cardiovascular disease beyond the current traditional cardiovascular risk factors.
buff.ly
June 7, 2025 at 10:54 AM
🗣️ #CirculatingCalprotectin identified as a crucial biomarker and potential therapeutic target of fulminant myocarditis.

High levels associated with longer hospital stays and higher risks of adverse outcomes.

#CardioSky

www.sciencedirect.com/science/arti...
Plasma proteomics identifies S100A8/A9 as a novel biomarker and therapeutic target for fulminant myocarditis
Fulminant myocarditis (FM) is a lethal inflammatory myocardial disease characterized by rapid progression and poor prognosis. Investigating plasma pro…
www.sciencedirect.com
June 10, 2025 at 11:52 AM
👉S100A9 (subunit of #calprotectin) showed high sensitivity in detecting septic shock and forecasting clinical outcomes.

journals.plos.org/plosone/arti...
The role of S100A9 as a diagnostic and prognostic biomarker in septic shock
Background Sepsis is a severe and potentially fatal systemic condition marked by excessive immune defense against infection. Within this research, we explored the serum concentration of S100A9 during ...
journals.plos.org
June 10, 2025 at 11:50 AM